Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. - van der Bom,J.G.; de Knijff,P.; Haverkate,F.; Bots,M.; Meijer,P.; de Jong,P.T.; Hofman,A.; Kluft,C.; Grobbee,D.E. (Circulation, 1997)